The present invention is directed to B7-H3 x CD3 bispecific monovalent diabodies, and particularly, to B7-H3 x CD3 bispecific monovalent Fc diabodies, that are capable of simultaneous binding to B7-H3 and CD3. The invention is also directed to pharmaceutical compositions that contain such bispecific monovalent Fc diabodies. The invention is additionally directed to methods for the use of such diabodies in the treatment of cancer and other diseases and conditions.本發明涉及B7-H3 x CD3雙特異性單價雙抗體,尤其涉及B7-H3 x CD3雙特異性單價Fc雙抗體,其能夠同時結合至B7-H3和CD3。本發明也涉及包含這類雙特異性單價Fc雙抗體的藥物組合物。本發明另外涉及這類雙抗體在治療癌症和其他疾病和病況中的應用的方法。